Tweeting from Medicinal Cannabis and Psychoactive Plants Research Forum at UniMelb. @DrSuziNielsen on promising preclinical evidence for cannabinoids to reduce opioid use in addiction. But "there isn't the science to support use and there isn't the support to do the science."
See the comment from the NHMRC reviewer.
Fascinating evidence from USA that #MDMA a helpful adjunct to psychotherapy for #PTSD, presented by Rick Doblin and Ingmar Gorman.
Rick Doblin: one case of elevated blood pressure in 500 people treated. Some required help managing emotions, uncovered memories, in the days following MDMA treatment.
Dr Martin Williams of @PRISMNews & @MindMedicineAU presents data on potential of psilocybin (magic mushroom active agent) in treating substance dependence, depression and anxiety.
Trial of psilocybin-assisted psychotherapy for anxiety in cancer or palliative patients about to begin at St Vincents Melbourne.
Prof John Skerritt of Therapeutic Goods Administration explaining pathways for prescribing and approval of medicinal cannabis. Estimates Australia soon to hit 10,000 prescriptions written.
Reasons for prescriptions for medicinal cannabis in Australia. Data from TGA presented by Dr Melissa Benson from Sydney's Lambert Institute
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.